2-[2-[1-[(4-chlorophenyl)methyl]indol-3-yl]ethyl]-4,7-difluoroisoindole-1,3-dione
C25H17ClF2N2O2 — CID 44758645
Data last refreshed: (MolForge compound catalog, from PubChem)
About 2-[2-[1-[(4-chlorophenyl)methyl]indol-3-yl]ethyl]-4,7-difluoroisoindole-1,3-dione
2-[2-[1-[(4-chlorophenyl)methyl]indol-3-yl]ethyl]-4,7-difluoroisoindole-1,3-dione (PubChem CID 44758645) has the molecular formula C25H17ClF2N2O2 and a molecular weight of 450.87 g/mol. Its IUPAC name is 2-[2-[1-[(4-chlorophenyl)methyl]indol-3-yl]ethyl]-4,7-difluoroisoindole-1,3-dione.
Molecular Properties
| Compound Name | 2-[2-[1-[(4-chlorophenyl)methyl]indol-3-yl]ethyl]-4,7-difluoroisoindole-1,3-dione |
|---|---|
| PubChem CID | 44758645 |
| Molecular Formula | C25H17ClF2N2O2 |
| Molecular Weight | 450.87 g/mol |
| Exact Mass | 450.09 |
| IUPAC Name | 2-[2-[1-[(4-chlorophenyl)methyl]indol-3-yl]ethyl]-4,7-difluoroisoindole-1,3-dione |
| SMILES | O=C1c2c(F)ccc(F)c2C(=O)N1CCc1cn(Cc2ccc(Cl)cc2)c2ccccc12 |
| InChI | InChI=1S/C25H17ClF2N2O2/c26-17-7-5-15(6-8-17)13-29-14-16(18-3-1-2-4-21(18)29)11-12-30-24(31)22-19(27)9-10-20(28)23(22)25(30)32/h1-10,14H,11-13H2 |
| InChIKey | OKQDPTXVAJWVDR-UHFFFAOYSA-N |
| XLogP | 5.46 |
| TPSA | 42.31 Ų |
| H-Bond Donors | |
| H-Bond Acceptors | 3 |
| Rotatable Bonds | 5 |
| Heavy Atoms | 32 |
| Complexity | — |
Lipinski Rule of Five
1 violation
| Rule | Value |
|---|---|
| MW ≤ 500 | 450.87 |
| LogP ≤ 5 | 5.46 |
| H-Bond Donors ≤ 5 | 0 |
| H-Bond Acceptors ≤ 10 | 3 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': 'phthalimide', 'substructure': 'N/A'} |
|---|
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 44758645 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.